Target intelligence / Profile preview

Ribosomal protein L27 pseudogene 4 (RPL27P4)

Target
RPL27P4
Molecular classification
Other (Pseudogene; not classified as receptor, enzyme, transporter, etc.)
01

Overview

RPL27P4 (ribosomal protein L27 pseudogene 4) is classified as a processed pseudogene, meaning it is a noncoding genomic sequence that shares homology with the functional ribosomal protein L27 gene but does not code for a functional protein[3][5]. Unlike its parent gene, RPL27, which produces a ribosomal protein important for ribosome structure and function[1][4], RPL27P4 is considered nonfunctional and does not participate in the synthesis of proteins or other cellular processes[3][5][12]. Pseudogenes like RPL27P4 are widespread in the human genome and typically arise by reverse transcription and genomic integration of mRNA from functional genes; only rarely do some pseudogenes retain partial regulatory activity or function, which is not documented for RPL27P4 in current literature[3][6]. Therefore, it is not regarded as a therapeutic target and has no known physiological or pathological relevance, drug interactions, or biomarker roles.

Other names
RPL27P4RPL27_1_28ribosomal protein L27 pseudogene
02

Biological functions

Other (Pseudogenes generally lack a biological function; they are noncoding and do not produce functional protein in most cases[3][6].)
03

Disease associations

Other (No direct disease association; parent protein RPL27 is linked to Diamond-Blackfan Anemia, but the pseudogene itself is not implicated in disease[4].)

Beyond the preview

Go deeper on Ribosomal protein L27 pseudogene 4 (RPL27P4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L27 pseudogene 4 (RPL27P4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call